全球血液分離設備市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計到 2034 年，血液分離設備市場規模將從 2025 年的 36.2 億美元成長至 83 億美元，2026 年至 2034 年的複合年成長率為 9.66%。

由於醫療領域對血液成分分離的需求不斷成長，全球血液分離設備市場正經歷顯著成長。血液分離術廣泛用於血漿採集、血小板捐贈以及各種自體免疫疾病和血液疾病的治療。慢性病盛行率的上升也增加了對先進血液處理技術的需求。

推動血液分離系統應用的主要因素包括醫療基礎設施的改善、捐血意識的提高以及自動化血液分離系統的技術進步。醫院和血庫正在投資購買高效設備，以確保操作安全可靠。細胞療法和再生醫學研究的擴展也促進了血液分離系統的使用。

隨著個人化醫療和先進生物製藥的進步，預計未來市場將持續成長。血漿衍生療法的推廣以及全球對免疫球蛋白的需求，可能會進一步加速相關設備的普及應用。持續創新，專注於提升病患的舒適度、安全性和治療效果，將塑造該市場的長期發展方向。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球血液分離設備市場：依產品分類

• 市場分析、洞察與預測
• 拋棄式血漿分離套裝
• 裝置

第5章 全球血液分離設備市場：依應用領域分類

• 市場分析、洞察與預測
• 腎臟疾病
• 血液學
• 神經病學
• 其他

第6章 全球血液分離設備市場：依程序分類

• 市場分析、洞察與預測
• 血漿置換療法
• 光化學療法
• 白血球分離術
• 血小板去除方法
• 低密度脂蛋白血漿置換術
• 紅血球分離方法
• 其他

第7章 全球血液分離設備市場：依技術分類

• 市場分析、洞察與預測
• 薄膜過濾
• 離心分離

第8章 全球血液分離設備市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • B. Braun Melsungen AG
  • Haemonetics Corporation
  • Fresenius Kabi AG
  • Asahi Kasei Medical Co. Ltd
  • Terumo BCT Inc
  • Mallinckrodt Plc
  • Nikkiso Europe GmbH
  • Cerus Corporation
  • Baxter International Inc
  • Kawasumi Laboratories Inc

The Apheresis Equipment Market size is expected to reach USD 8.30 Billion in 2034 from USD 3.62 Billion (2025) growing at a CAGR of 9.66% during 2026-2034.

The Global Apheresis Equipment Market is growing significantly due to increasing demand for blood component separation in medical treatments. Apheresis procedures are commonly used for plasma collection, platelet donation, and therapeutic treatments for various autoimmune and hematological disorders. The rising prevalence of chronic diseases is boosting the need for advanced blood processing technologies.

Drivers include improvements in healthcare infrastructure, growing awareness about blood donation, and technological advancements in automated apheresis systems. Hospitals and blood banks are investing in efficient equipment to ensure safe and reliable procedures. Expanding research in cell therapy and regenerative medicine is also contributing to increased utilization of apheresis systems.

Future growth is expected as personalized medicine and advanced biologics gain momentum. The expansion of plasma-derived therapies and global demand for immunoglobulins may further drive equipment adoption. Continuous innovation focused on patient comfort, safety, and procedural efficiency will likely shape the long-term trajectory of this market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Disposable Apheresis Kits
• Devices

By Application

• Renal Diseases
• Hematology
• Neurology
• Others

By Procedure

• Plasmapheresis
• Photopheresis
• Leukapheresis
• Plateletpheresis
• LDL Apheresis
• Erythrocytapheresis
• Others

By Technology

• Membrane Filtration
• Centrifugation

COMPANIES PROFILED

• B Braun Melsungen AG, Haemonetics Corporation, Fresenius Kabi AG, Asahi Kasei Medical Co Ltd, Terumo BCT Inc, Mallinckrodt Plc, Nikkiso Europe GmbH, Cerus Corporation, Baxter International Inc, Kawasumi Laboratories Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL APHERESIS EQUIPMENT MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Disposable Apheresis Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL APHERESIS EQUIPMENT MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Renal Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Hematology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL APHERESIS EQUIPMENT MARKET: BY PROCEDURE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Procedure
• 6.2. Plasmapheresis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Photopheresis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Leukapheresis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Plateletpheresis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. LDL Apheresis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Erythrocytapheresis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL APHERESIS EQUIPMENT MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Technology
• 7.2. Membrane Filtration Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Centrifugation Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL APHERESIS EQUIPMENT MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Application
  • 8.2.3 By Procedure
  • 8.2.4 By Technology
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Application
  • 8.3.3 By Procedure
  • 8.3.4 By Technology
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Application
  • 8.4.3 By Procedure
  • 8.4.4 By Technology
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Application
  • 8.5.3 By Procedure
  • 8.5.4 By Technology
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Application
  • 8.6.3 By Procedure
  • 8.6.4 By Technology
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL APHERESIS EQUIPMENT INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 B. Braun Melsungen AG
  • 10.2.2 Haemonetics Corporation
  • 10.2.3 Fresenius Kabi AG
  • 10.2.4 Asahi Kasei Medical Co. Ltd
  • 10.2.5 Terumo BCT Inc
  • 10.2.6 Mallinckrodt Plc
  • 10.2.7 Nikkiso Europe GmbH
  • 10.2.8 Cerus Corporation
  • 10.2.9 Baxter International Inc
  • 10.2.10 Kawasumi Laboratories Inc